SPONSOR
Hebei Medical University Fourth Hospital
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Malignant NeoplasmOrgan DamageBreast CancerRectal CancerTriple Negative Breast CancerNab-paclitaxelEsophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Malignant Neoplasm, Organ Damage, Breast Cancer, Rectal Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hebei Medical University Fourth Hospital
How many clinical trials has Hebei Medical University Fourth Hospital sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Hebei Medical University Fourth Hospital, of which 5 are actively recruiting participants. These trials cover conditions including Malignant Neoplasm, Organ Damage, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hebei Medical University Fourth Hospital research focus on?
Hebei Medical University Fourth Hospital clinical trials span Malignant Neoplasm, Organ Damage, Breast Cancer, Rectal Cancer, Triple Negative Breast Cancer, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hebei Medical University Fourth Hospital clinical trial?
To participate in a Hebei Medical University Fourth Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hebei Medical University Fourth Hospital trials with current recruitment status updated daily.
Clinical Trials by Hebei Medical University Fourth Hospital
NCT07131007
Recruiting
Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics
Malignant Neoplasm
NCT05578053
Recruiting
Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer
Breast Cancer
NCT06210971 Phase 2
Recruiting
Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
Rectal Cancer
NCT04159142 Phase 2
Recruiting
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
Triple Negative Breast Cancer
NCT07290010 Phase 2
Recruiting
The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma (ESCC)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology